These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32804830)

  • 1. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
    Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
    Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
    Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
    Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia.
    Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
    Eye (Lond); 2022 Aug; 36(8):1623-1630. PubMed ID: 34326496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHARACTERIZING RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2 WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Breazzano MP; Yannuzzi LA; Spaide RF
    Retina; 2020 Jan; 40(1):92-98. PubMed ID: 31246676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
    Dogan B; Erol MK; Akidan M; Suren E; Akar Y
    Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
    Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
    Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
    Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
    Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
    Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study.
    Singh SR; Fraser-Bell S; Dogra A; Sahoo NK; Gabrielle PH; Lupidi M; Al-Sheikh M; Borrelli E; Sacconi R; Querques G; Chhablani J
    Eur J Ophthalmol; 2021 Jul; 31(4):1933-1939. PubMed ID: 32613846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
    Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
    Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
    Park YG; Park YH
    PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swept source optical coherence tomography analysis of choroidal thickness in macular telangiectasia type 2: a case-control study.
    Kumar V; Kumawat D; Kumar P
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):567-573. PubMed ID: 30560414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OUTER FOVEAL DEFECTS IN TYPE-2 MACULAR TELANGIECTASIA.
    Chandran K; Giridhar A; Gayathri MS; Antison M; Gopalakrishnan M; Sivaprasad S
    Retina; 2023 Jan; 43(1):111-119. PubMed ID: 36542082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.